|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Cardiovascular Systems, Inc. Reports Data from Compliance 360° Study Comparing Orbital Atherectomy vs. Percutaneous Transluminal Angioplasty
6/14/2012 11:26:58 AM
ST. PAUL, Minn. & NEW ORLEANS--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), shared 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the New Cardiovascular Horizons Annual Conference on Saturday, June 9, 2012. Dr. Barry Weinstock, Interventional Cardiologist, Orlando Regional Medical Center, Winter Park, Fla., presented data demonstrating positive outcomes and cost comparisons to the widely used percutaneous transluminal angioplasty (PTA).
|
|
|
|
|
|
|
|
|
|
|